Study With Healthy Japanese and Non-Asian Participants With BMS-986231

Completed · Phase 1 · Has a placebo group

Conditions studied: Heart Decompensation, Acute

In brief

The purpose of this Phase 1 study is to evaluate the safety, tolerability, PK, and pharmacodynamics (PD) of BMS-986231 in healthy Japanese and Non-Asian participants. There is no formal hypothesis to be statistically tested.

Key facts

Study ID

NCT02932969

Run by

Bristol-Myers Squibb

People needed

56

Starts

2016-10-04

Expected to finish

2017-05-26

Last updated by the study team

2017-05-31

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ancestry
• First generation Japanese
• Non-Asian with grandparents and parents of non-Asian descent
• Body weight greater than or equal to 45kg and less than or equal to 110kg
• Women of childbearing potential have specific birthcontrol methods
• Males sexually active with women of childbearing potential have specific birthcontrol methods

You may not qualify if…

• History of chronic illness
• Chronic headaches
• Recurrent dizziness
• Personal or family history of heart disease
• Personal history of bleeding diathesis

Where it is running

• West Coast Clinical Trials, Llc — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.